Join Our Newsletter
Join our subscribers list to get the latest news, updates and special offers directly in your inbox
Tag: TargetedTherapy
Research Unveiled at ESMO 2025: MSK’s Groundbreaking Advances in Lung, Pancreatic, and Solid Tumor Cancer Treatments
Discover the latest cancer research breakthroughs from Memorial Sloan Kettering (MSK) presented at ESMO 2025, including new therapies for lung, pancreatic, and mismatch repair–deficient solid tumors. Explore the promising clinical results that may redefine future cancer care.
Breakthrough Cancer Therapy Halts Tumor Growth Without Harming Healthy Cells
Scientists at the Francis Crick Institute and Vividion Therapeutics have developed a new compound that blocks cancer’s growth signal without damaging healthy cells. The discovery, published in Science, marks a major advance in safer, targeted cancer treatments now entering human clinical trials.
